Loma Linda University Cancer Institute

Loma Linda, California 92354

0 studies enrolling now · 5 studies all time

What they study most

Breast Cancer, Head and Neck Cancer, NSCLC, Pancreatic Cancer, Squamous Cell Cancer

Studies at this site

• Zalutumumab in Non-curable Patients With SCCHN — Completed
• A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy. — Stopped early
• Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer — Completed
• OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer. — Completed
• Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen — Completed